Last reviewed · How we verify

NCT06792201

Evaluation of Sarcopenia in Women in Different Stages of Life and in Hormonal Therapy or Not

Recruiting now NA Last updated 24 January 2025
What this trial tests

NA trial testing SARC-F, Handgrip test, Chair stand test in Sarcopenia in 180 participants. Currently enrolling.

Timeline
14 June 2021
Primary endpoint
14 June 2025
14 June 2026

Quick facts

Lead sponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment180
Start date14 June 2021
Primary completion14 June 2025
Estimated completion14 June 2026
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna — full company profile →

Who can join

Adults 18 to 65, female only, with Sarcopenia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The three-year interventional study has the following objectives: The study aims to assess the prevalence of sarcopenia in menopausal women receiving hormone replacement therapy or not compared with pre-menopausal women. The study population will be divided into groups according to the intake or not of hormonal therapy of menopause as per normal clinical practice and the menopausal state: GROUP A - menopausal patient taking hormone therapy GROUP B - menopausal patient not taking hormone therapy GROUP C - pre-menopausal patients who do not take hormonal products The primary objective is to compare the strength and muscle mass outcomes of HRT in menopausal women compared with those who do not use it and women in pre-menopausal age. Survey methods such as SARC-F, Handgrip test, Chair stand test and bio impedance

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Advances in electrical stimulation-based therapeutic technologies for sarcopenia prevention and treatment.
    Rahaman KA, Kim MJ, Jung Y, Kang SK, et al · · 2026 · PMID 41727275 · DOI 10.1016/j.bioactmat.2026.01.035

Verify or expand the search:

Other recruiting trials for Sarcopenia

Currently open trials in the same condition.

Other IRCCS Azienda Ospedaliero-Universitaria di Bologna trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06792201.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing